Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   


go back to main search page
Accession:CHEBI:85605 term browser browse the term
Definition:A tetrachloro(cyclohexane-1,2-diamine-kappa(2)N,N')platinum that is the pharmacologically active (1R,2R)-enantiomer of ormaplatin.
Synonyms:exact_synonym: tetrachloro[(1R,2R)-cyclohexane-1,2-diamine-kappa(2)N,N']platinum
 related_synonym: (+)-trans-Tetrachloro(1,2-cyclohexanediamine)platinum;   (1R,2R)-ormaplatin;   Formula=C6H14Cl4N2Pt;   InChI=1S/C6H14N2.4ClH.Pt/c7-5-3-1-2-4-6(5)8;;;;;/h5-6H,1-4,7-8H2;4*1H;/q;;;;;+4/p-4/t5-,6-;;;;;/m1...../s1;   InChIKey=VPOCYEOOFRNHNL-RQDPQJJXSA-J;   SMILES=Cl[Pt--]1(Cl)(Cl)(Cl)[NH2+][C@@H]2CCCC[C@H]2[NH2+]1;   U-78,938
 xref: CAS:96392-96-0 "ChemIDplus";   KEGG:D03723;   Patent:CN101081206;   Patent:CN101273964;   Patent:CN101283978;   Reaxys:13498176 "Reaxys"

show annotations for term's descendants       view all columns           Sort by:

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19596
    role 19539
      biological role 19537
        aetiopathogenetic role 18679
          neurotoxin 17250
            dexormaplatin 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19596
    subatomic particle 19592
      composite particle 19592
        hadron 19592
          baryon 19592
            nucleon 19592
              atomic nucleus 19592
                atom 19592
                  metal atom 16970
                    transition element atom 16448
                      d-block element atom 16435
                        nickel group element atom 10064
                          platinum 8365
                            platinum molecular entity 8365
                              platinum coordination entity 8365
                                tetrachloro(cyclohexane-1,2-diamine-kappa(2)N,N')platinum 0
                                  dexormaplatin 0
paths to the root


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.